210 related articles for article (PubMed ID: 35701626)
21. Evidence of a Sjögren's disease-like phenotype following COVID-19 in mice and humans.
Shen Y; Voigt A; Goranova L; Abed M; Kleiner DE; Maldonado JO; Beach M; Pelayo E; Chiorini JA; Craft WF; Ostrov DA; Ramiya V; Sukumaran S; Brown AN; Hanrahan KC; Tuanyok A; Warner BM; Nguyen CQ
JCI Insight; 2023 Dec; 8(24):. PubMed ID: 37676726
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a Sjögren's disease-like phenotype following COVID-19.
Shen Y; Voigt A; Goranova L; Abed M; Kleiner DE; Maldonado JO; Beach M; Pelayo E; Chiorini JA; Craft WF; Ostrov DA; Ramiya V; Sukumaran S; Tuanyok A; Warner BM; Nguyen CQ
medRxiv; 2022 Oct; ():. PubMed ID: 36324812
[TBL] [Abstract][Full Text] [Related]
23. Sjögren's syndrome in patients with newly diagnosed untreated non-Hodgkin's lymphoma.
Andonopoulos AP; Tiniakou M; Melachrinou M; Sfountouris H; Bounas A; Zervas C; Zoumbos NC
Rev Rhum Engl Ed; 1997 May; 64(5):287-92. PubMed ID: 9190001
[TBL] [Abstract][Full Text] [Related]
24. Ruxolitinib inhibits IFNγ-stimulated Sjögren's salivary gland MSC HLA-DR expression and chemokine-dependent T cell migration.
McCoy SS; Parker M; Gurevic I; Das R; Pennati A; Galipeau J
Rheumatology (Oxford); 2022 Oct; 61(10):4207-4218. PubMed ID: 35218354
[TBL] [Abstract][Full Text] [Related]
25. Optic Neuropathy Associated with Primary Sjögren's Syndrome: A Case Series.
Bak E; Yang HK; Hwang JM
Optom Vis Sci; 2017 Apr; 94(4):519-526. PubMed ID: 28272192
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing the EULAR Sjögren's Syndrome Patient-Reported Index in primary Sjögren's syndrome.
Sandoval-Flores MG; Chan-Campos I; Hernández-Molina G
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):153-158. PubMed ID: 34128801
[TBL] [Abstract][Full Text] [Related]
27. Can ultrasound of the major salivary glands differentiate Sjögren's disease from its major mimics?
Delli K; Van Nimwegen JF; Arends S; Stel AJ; Gan CT; Bierman WFW; Spijkervet FKL; Bootsma H; Vissink A
Clin Exp Rheumatol; 2023 Dec; 41(12):2467-2473. PubMed ID: 38079345
[TBL] [Abstract][Full Text] [Related]
28. Anti-salivary gland protein 1 antibodies in two patients with Sjogren's syndrome: two case reports.
Vishwanath S; Shen L; Suresh L; Ambrus JL
J Med Case Rep; 2014 May; 8():145. PubMed ID: 24885364
[TBL] [Abstract][Full Text] [Related]
29. The influence of sex steroids on Sjögren's syndrome.
Porola P; Laine M; Virkki L; Poduval P; Konttinen YT
Ann N Y Acad Sci; 2007 Jun; 1108():426-32. PubMed ID: 17894007
[TBL] [Abstract][Full Text] [Related]
30. The Potential Utility of Salivary and Tear Proteomics to Discriminate Sjögren's Disease from Non-Sjögren's Sicca.
George CT; Kurien BT; Scofield RH
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139325
[TBL] [Abstract][Full Text] [Related]
31. Increased utilisation of eye disorder-related ambulatory medical services prior to the diagnosis of Sjögren's syndrome in female patients: a longitudinal population-based study in Taiwan.
Lu MC; Fa WH; Tsai TY; Koo M; Lai NS
BMJ Open; 2014 May; 4(5):e003862. PubMed ID: 24844268
[TBL] [Abstract][Full Text] [Related]
32. Novel autoantibodies help diagnose anti-SSA antibody negative Sjögren disease and predict abnormal labial salivary gland pathology.
Parker M; Zheng Z; Lasarev MR; Larsen MC; Vande Loo A; Alexandridis RA; Newton MA; Shelef MA; McCoy SS
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38702176
[TBL] [Abstract][Full Text] [Related]
33. Emerging treatment for Sjögren's disease: a review of recent phase II and III trials.
Fox RI; Fox CM; McCoy SS
Expert Opin Emerg Drugs; 2023 Dec; 28(2):107-120. PubMed ID: 37127914
[TBL] [Abstract][Full Text] [Related]
34. Use and efficacy of dry-mouth interventions in Sjögren's disease patients and possible association with perceived oral dryness and patients' discomfort.
Assy Z; van Santen JS; Brand HS; Bikker FJ
Clin Oral Investig; 2023 Sep; 27(9):5529-5537. PubMed ID: 37507599
[TBL] [Abstract][Full Text] [Related]
35. Fibromyalgia in 300 adult index patients with primary immunodeficiency.
Barton JC; Bertoli LF; Barton JC; Acton RT
Clin Exp Rheumatol; 2017; 35 Suppl 105(3):68-73. PubMed ID: 28422000
[TBL] [Abstract][Full Text] [Related]
36. Association Between Endometriosis and Subsequent Risk of Sjögren's Syndrome: A Nationwide Population-Based Cohort Study.
Chao YH; Liu CH; Pan YA; Yen FS; Chiou JY; Wei JC
Front Immunol; 2022; 13():845944. PubMed ID: 35592328
[TBL] [Abstract][Full Text] [Related]
37. Sporadic inclusion body myositis and primary Sjogren's syndrome: an overlooked diagnosis.
Chung SH; Bent EI; Weiss MD; Gardner GC
Clin Rheumatol; 2021 Oct; 40(10):4089-4094. PubMed ID: 33884496
[TBL] [Abstract][Full Text] [Related]
38. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
[TBL] [Abstract][Full Text] [Related]
39. Anti-Sjögren's-syndrome-related antigen A autoantibodies (Anti-SSA antibody) and meningoencephalitis: Sjögren's syndrome waiting to be unveiled? A case series and review of literature.
Mittal GK; Mittal S; Kaur H; Stephen SR; Sekhar S; Sureshbabu S; Sandhya P
Rheumatol Int; 2021 Oct; 41(10):1855-1866. PubMed ID: 33040168
[TBL] [Abstract][Full Text] [Related]
40. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.
Zhang Y; Luo Q; Lu K; You M; Wang H
Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
